Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
Cipla
Argus Health
Julphar
Deloitte

Generated: April 19, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,303,661

« Back to Dashboard

Summary for Patent: 6,303,661
Title: Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals
Abstract:Novel therapeutic regimens are provided which comprise the administration of therapeutically effective amounts of an inhibitor to dipeptidyl peptidase (DP-IV) or enzymes of similar activity whereby their ability to degrade the incretins, GLP-1 and GIP, is reduced. As a result hyperglycemia, such as that accompanying food intake may be reduced due to improved insulin release. A preferred therapeutic regimen amongst a number of routes of administration and inhibitors that may be used comprises the oral administration of isoleucyl thiazolidine.
Inventor(s): Demuth; Hans-Ulrich (Halle, DE), Rosche; Fred (Dieskau, DE), Schmidt; Joem (Halle, DE), Pauly; Robert P. (Vancouver, CA), McIntosh; Christopher H. S. (Vancouver, CA), Pederson; Ray A. (Vancouver, CA)
Assignee: Probiodrug (Weinbergweg, DE)
Application Number:09/155,833
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,303,661
Patent Claim Types:
see list of patent claims
Use; Dosage form; Composition;

Drugs Protected by US Patent 6,303,661

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,303,661

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany196 16 486Apr 25, 1996
PCT Information
PCT FiledApril 24, 1997PCT Application Number:PCT/DE97/00820
PCT Publication Date:November 06, 1997PCT Publication Number: WO97/40832

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Fish and Richardson
Colorcon
Chinese Patent Office
Queensland Health
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.